- Home
- TLSI vs EP Comparison
TLSI vs EP Comparison
Compare TLSI & EP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLSI | EP |
|---|---|---|
| Founded | 2010 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.3M | 106.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TLSI | EP |
|---|---|---|
| Price | $6.89 | $3.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | ★ 232.5K | 34.9K |
| Earning Date | 11-13-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $40,207,000.00 | $37,880,178.00 |
| Revenue This Year | $55.06 | N/A |
| Revenue Next Year | $46.04 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 49.52 | N/A |
| 52 Week Low | $3.42 | $2.78 |
| 52 Week High | $7.95 | $8.12 |
Technical Indicators
Market Signals| Indicator | TLSI | EP |
|---|---|---|
| Relative Strength Index (RSI) | 54.55 | 43.47 |
| Support Level | $6.80 | $2.85 |
| Resistance Level | $7.95 | $3.33 |
| Average True Range (ATR) | 0.46 | 0.22 |
| MACD | -0.11 | -0.01 |
| Stochastic Oscillator | 14.06 | 20.00 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About EP Empire Petroleum Corporation
Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the United States onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.